Clone: DCS121.
Background: The immunogen for the anti CDC25A was a purified recombinant CDC25A protein recognizing a 65kD protein. In the cell cycle of eukaryotes the M phase is initiated by maturation promoting factor (MPF), a protein kinase complex consisting of p34 cdc2, cyclin B, and p13. The activity of this complex is controlled by multiple levels of phosphorylation and dephosphorylation of the catalytic p34cdc2 component. CDC25A and CDC25B arep34cdc2 tyrosine phosphates. Dephosphorylation of p34cdc2 by these CDC25 proteins activates the MPF complex, initiating mitosis. Although expressed throughout the cell cycle, peak expression of CDC25A is in G1 of the cell cycle.
Purification Method: Protein A/G Chromatography.
Source: Mice were immunized with a purified recombinant CDC25A protein of 65kD protein.
Formulation: Provided as solution in phosphate buffered saline with 0.08% sodium azide.
References: 1. Wang, Z., et al. 'Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes.' BMC Cancer 2010, 10, 233
2. Berthet, C., et al. 'How adeno-associated virus Rep78 protein arrests cells completely in S phase.' Proc. Natl. Acad. Sci. 2005, 102, 13634-13639.
UniProt: P30304 (Human).
Caution: This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals.
English
Deutsch
